Zhigang Kang
- Molecular Biology
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Immunology
- Co-authors
- Liang CaoOlli A. JänneJorma J. PalvimoRamdane HarouakaAsta PirskanenRavi A. MadanElizabeth LampingItalia Grenga
- Topics
- Cell death mechanisms and regulation (4 papers)Sarcoma Diagnosis and Treatment (3 papers)Prostate Cancer Treatment and Research (3 papers)
- Partner nations
- United StatesFinlandItaly
In The Last Decade
Zhigang Kang
17 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Molecular Biology 483
- Oncology 483
- Pulmonary and Respiratory Medicine 303
- Cancer Research 204
- Immunology 173
Countries citing papers authored by Zhigang Kang
This map shows the geographic impact of Zhigang Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhigang Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhigang Kang more than expected).
Fields of papers citing papers by Zhigang Kang
This network shows the impact of papers produced by Zhigang Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhigang Kang. The network helps show where Zhigang Kang may publish in the future.
Co-authorship network of co-authors of Zhigang Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Zhigang Kang. A scholar is included among the top collaborators of Zhigang Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhigang Kang. Zhigang Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 25 | |
| 3 | 5 | |
| 4 | Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumorsbreakdown → | 327 |
| 5 | 9 | |
| 6 | 71 | |
| 7 | 6 | |
| 8 | 22 | |
| 9 | 1 | |
| 10 | 20 | |
| 11 | 163 | |
| 12 | 9 | |
| 13 | 39 | |
| 14 | 26 | |
| 15 | 2 | |
| 16 | 144 | |
| 17 | 162 | |
| 18 | 31 |
About Zhigang Kang
Zhigang Kang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Oncology (483 citations), Cancer Research (204 citations) and Pulmonary and Respiratory Medicine (303 citations). Zhigang Kang has collaborated with scholars based in United States, Finland and Italy. Frequent co-authors include Liang Cao, Olli A. Jänne, Jorma J. Palvimo, Ramdane Harouaka, Asta Pirskanen, Ravi A. Madan, Elizabeth Lamping, Italia Grenga, Renee N. Donahue and Jennifer L. Marté. Their work appears in journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.